Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pitolisant for Alcohol Self-Administration in Heavy Drinkers
NCT04596267Phase 1Terminated
- Sponsor
- Boston Medical Center
- Start
- Sep 2021
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in alcohol use disorder (AUD) comparing Pitolisant with Placebo (2 arms). Primary endpoints: Alcohol Consumption in Alcohol Self-Administration Trials at 2.6 hours and Alcohol Consumption (BAC). Started Sep 2021; status: terminated.
02
Drugs
pitolisant
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT04596267.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04596267.